Chemically modified RNA induces osteogenesis of stem cells and human tissue explants as well as accelerates bone healing in rats.

[1]  D. R. Sumner,et al.  Chemically modified RNA activated matrices enhance bone regeneration. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[2]  E. Balmayor,et al.  Gene Therapy for Bone Engineering , 2015, Front. Bioeng. Biotechnol..

[3]  N. Demirkan,et al.  Local rhBMP-2 Injection after Drill-Hole Injury in Rats: Does it Have Systemic Effects? , 2014, International journal of immunopathology and pharmacology.

[4]  J. Hilborn,et al.  Complexation and Sequestration of BMP-2 from an ECM Mimetic Hyaluronan Gel for Improved Bone Formation , 2013, PloS one.

[5]  P. Dubey,et al.  Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering , 2013, Expert opinion on drug delivery.

[6]  E. Balmayor,et al.  Human Placental Alkaline Phosphatase as a Tracking Marker for Bone Marrow Mesenchymal Stem Cells , 2013, BioResearch open access.

[7]  M. Brandi,et al.  Drug delivery using composite scaffolds in the context of bone tissue engineering. , 2013, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

[8]  M. Poddar,et al.  Sustained Release of Bone Morphogenetic Protein 2 via Coacervate Improves the Osteogenic Potential of Muscle‐Derived Stem Cells , 2013, Stem cells translational medicine.

[9]  Alpesh A. Patel,et al.  Complications Associated With the Use of the Recombinant Human Bone Morphogenetic Proteins for Posterior Interbody Fusions of the Lumbar Spine , 2013, Spine.

[10]  N. Epstein,et al.  Complications due to the use of BMP/INFUSE in spine surgery: The evidence continues to mount , 2013, Surgical neurology international.

[11]  M. Idzko,et al.  Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism. , 2013, The Journal of clinical investigation.

[12]  R. Reis,et al.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems. , 2013, Tissue engineering. Part B, Reviews.

[13]  P. Aspenberg.  Special Review: Accelerating fracture repair in humans: a reading of old experiments and recent clinical trials. , 2013, BoneKEy reports.

[14]  James Kang,et al.  Bone morphogenetic protein in spine surgery: current and future uses. , 2012, The Journal of the American Academy of Orthopaedic Surgeons.

[15]  C. Evans,et al.  Gene delivery to bone. , 2012, Advanced drug delivery reviews.

[16]  C. Laurencin,et al.  The role of small molecules in musculoskeletal regeneration. , 2012, Regenerative medicine.

[17]  D. Hutmacher,et al.  A Tissue Engineering Solution for Segmental Defect Regeneration in Load-Bearing Long Bones , 2012, Science Translational Medicine.

[18]  J. Dettori,et al.  The use of rhBMP in spine surgery: is there a cancer risk? , 2012, Evidence-Based Spine-Care Journal.

[19]  R. Braren,et al.  Silica-Iron Oxide Magnetic Nanoparticles Modified for Gene Delivery: A Search for Optimum and Quantitative Criteria , 2012, Pharmaceutical Research.

[20]  D. Kaplan,et al.  An Ectopic Study of Apatite-Coated Silk Fibroin Scaffolds Seeded with AdBMP-2-Modified Canine bMSCs , 2012, Journal of biomaterials science. Polymer edition.

[21]  Ralph Müller,et al.  Engineering the Growth Factor Microenvironment with Fibronectin Domains to Promote Wound and Bone Tissue Healing , 2011, Science Translational Medicine.

[22]  Christian Plank,et al.  Magnetically enhanced nucleic acid delivery. Ten years of magnetofection—Progress and prospects , 2011, Advanced Drug Delivery Reviews.

[23]  M. van Griensven,et al.  Human adipose derived stem cells reduce callus volume upon BMP-2 administration in bone regeneration. , 2011, Injury.

[24]  Bradley K Weiner,et al.  A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. , 2011, The spine journal : official journal of the North American Spine Society.

[25]  J. Rosenecker,et al.  Expression of therapeutic proteins after delivery of chemically modified mRNA in mice , 2011, Nature Biotechnology.

[26]  K E Tanner.  Bioactive composites for bone tissue engineering , 2010, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[27]  Sandra J Shefelbine,et al.  BoneJ: Free and extensible bone image analysis in ImageJ. , 2010, Bone.

[28]  K E Tanner,et al.  Bioactive ceramic-reinforced composites for bone augmentation , 2010, Journal of The Royal Society Interface.

[29]  Benjamin Schmid,et al.  A high-level 3D visualization API for Java and ImageJ , 2010, BMC Bioinformatics.

[30]  H. Deutsch.  High-dose bone morphogenetic protein-induced ectopic abdomen bone growth. , 2010, The spine journal : official journal of the North American Spine Society.

[31]  P. Williams,et al.  Development of Viral Vectors for Use in Cardiovascular Gene Therapy , 2010, Viruses.

[32]  J. Hoyland,et al.  Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. , 2009, European cells & materials.

[33]  L. Jeng,et al.  LARGE‐SCALE BICORTICAL SKULL BONE REGENERATION USING EX VIVO REPLICATION‐DEFECTIVE ADENOVIRAL‐MEDIATED BONE MORPHOGENETIC PROTEIN—2 GENE—TRANSFERRED BONE MARROW STROMAL CELLS AND COMPOSITE BIOMATERIALS , 2009, Neurosurgery.

[34]  Hajime Ohgushi,et al.  Comparison of Osteogenic Ability of Rat Mesenchymal Stem Cells from Bone Marrow, Periosteum, and Adipose Tissue , 2008, Calcified Tissue International.

[35]  Z. Berneman,et al.  mRNA-based gene transfer as a tool for gene and cell therapy. , 2007, Current opinion in molecular therapeutics.

[36]  Mark Vrahas,et al.  Facilitated endogenous repair: making tissue engineering simple, practical, and economical. , 2007, Tissue engineering.

[37]  G. Hagan,et al.  RNAi-based gene silencing in primary mouse and human adipose tissues Published, JLR Papers in Press, November 8, 2006. , 2007, Journal of Lipid Research.

[38]  U. Şahin,et al.  Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. , 2006, Blood.

[39]  G. Im,et al.  Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? , 2005, Osteoarthritis and cartilage.

[40]  J. Dragoo,et al.  Tissue-Engineered Bone from BMP-2–Transduced Stem Cells Derived from Human Fat , 2005, Plastic and reconstructive surgery.

[41]  Kazuhiro Sudo,et al.  Efficient Transfection of Embryonic and Adult Stem Cells , 2004, Stem cells.

[42]  Toshitaka Nakamura,et al.  Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. , 2004, Bone.

[43]  F. Kloss,et al.  Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes , 2003, Gene Therapy.

[44]  V. Singer,et al.  A High-resolution, Fluorescence-based Method for Localization of Endogenous Alkaline Phosphatase Activity , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[45]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .